期刊文献+

乳腺癌非哨兵淋巴结转移的预测 被引量:2

Prediction of metastases to non-sentinel lymph node in invasive breast cancer
下载PDF
导出
摘要 目的探讨乳腺癌非哨兵淋巴结(non-sentinellymphnode,NSN)转移预测的临床因素。方法回顾该科近2年来230例乳腺癌患者行哨兵淋巴结活检(sentinellymphnodebiopsy,SLNB),后行腋窝淋巴结清扫术(axillarylymphnodedissection,ALND)。有哨兵淋巴结(sentinellymphnode,SN)转移的94例,分析其中非哨兵淋巴结(NSN)转移的患者与临床因素的关系。结果SN有转移的94例患者,67例(72.27%)有NSN转移;原发肿瘤的大小(P<0.01),SN转移的个数(P<0.05),组织学病理分级(P<0.05)是预测NSN转移的指标。将3个因素联合起来预测NSN转移可达到94.12%(16/17)(P>0.05);而患者年龄,肿瘤生长位置、病理类型、ER、PR、C-erbB-2(Her-2/neu)、P53、nm23表达与否对NSN转移预测无统计学意义(P>0.05)。结论乳腺癌原发病灶的大小,SN转移的个数,组织学病理分级或3个因素联合分析对预测NSN的转移有重要意义。 [Objective] To investigate the predictive factors of non-sentinel lymph node (NSN) metastases in women with invasive breast cancer. [Methods] Aprospective data was analyzed and enrolled patients (n = 230) who underwent sentinel lymph node biopsy (SLNB) follow axillary lymph node dissection (ALND) for invasive breast cancer in the recent 2 years. 90 (40.86%) patients had one or more positive SLNs and were analyzed to determine factors that predicted additional positive axillary nodes. [Results] Of the 94 patients with positive SLN, 67 (71.27%) patients had additional metastasis in NSN. The significant variables that predicted NSN metastasis were tumor size (P 〈0.01), number of positive SLN (P 〈0.05), and unclear grade (P 〈0.05). The accuracy of the combination of the three factors in predicting NSN metastases was 94.12% (16/17) (P 〉0.05). The age, tumor location, histologic type, estrogen and progesterone receptors (ER, PR), C-erbB-2 (Her-2/neu), P53, nm23 status had no effect on NSN metastases (P 〉0.05). [Conclusion] Tumor size, number of positive SLN, unclear grade and the combination of those three factors are important in predicting NSN metastasis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第5期608-610,共3页 China Journal of Modern Medicine
关键词 乳腺癌 哨兵淋巴结 转移 breast cancer sentinel lymph node metastases
  • 相关文献

参考文献14

  • 1中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2007版)[J].中国癌症杂志,2007,17(5):410-428. 被引量:232
  • 2申郑堂,欧慧英,邬玉辉,海健,王守满.乳腺癌前哨淋巴结检出率的影响因素[J].中国普通外科杂志,2005,14(9):708-710. 被引量:10
  • 3ANEES BC, CHARLES RS, ROBERT CG, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer[J]. A J Surgery, 2006, 192(6): 882-887.
  • 4CHENG JY, GINCHENY HSU, CHANG BH, et al. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan [J]. World J Surg, 2005, 29(7): 813-819.
  • 5DEGNIM AC, REYNOLDS C, PANTVAIDYA G, et al. Nosentine node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram [J]. Am J Surg, 2005, 190(4): 543-550.
  • 6HUNG W, CHAN MC, MAK K, et al. Non-sentinel lymph node metastasis in breast cancer patients with metastatic sentinel [J]. Aust N Z J Surg, 2005, 75(1): 27-31.
  • 7GNYAL A, DOUGLAS JA, NEWCOMBE RG, et al. Predictors of non-sentinel node metastasis in breast cancer patients [J]. European J Cancer, 2004, 40(1): 1731-1737.
  • 8RIVERS AK, GRIFLITK KA, HUNT KK, et al. Clinicopathologic features associated with having four or more metastasis axillary nodes in breast cancer patients with a positive sentinel lymph node[J]. Ann Surg Oncol, 2006, 13(1): 36-44.
  • 9CAOY, PANER GP, RAJAN PB, et al. Sentinel node status and tumor characteristics: A study of 234 invasive breast cancer [J]. Arch Pathology Laboratory Medicine, 2005, 129(1): 82-83.
  • 10SCHRENK P, KONSTANTINIUK P, WOLFL S, et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node[J]. Br J Surg, 2005, 92(6): 707-713.

二级参考文献9

  • 1Sandral L, Wong MD, Micheal J, et al. Predicting the status of the nonsenitel axillary node. A multicenter Study [ J ] .Arch Surg, 2001 ,136(5) :563 -568.
  • 2Blessing WD. Stolier A J, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping [J]. Am J Surg, 2002, 184(4) : 341 -345.
  • 3Ahrendt GM, Laud P. Tjoe J, et al. Does breast tumor location influence success of sentinel lymph node biopsy? [ J ]. J Am Coil Surg,2002, 194(3) :278 -284.
  • 4Noguchi M, Motomura K, lomoto S, et al. A multicentric validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society [ J ]. Breas Cancer Res Treat, 2000, 63(1):31 -40.
  • 5Chao C, Wang SL, Woo C, et al. Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast [J]. Am J Surg 2001 , 182(4) :307 -311.
  • 6Wong SL, Edwards MJ, Chao C, et al. The effect of prior and concurrent definitive breast procedure on sentinel and accuracy of sentinel lymph node biopsy[ J ]. Ann Surg Oncol, 2002,9(2) : 272 -277.
  • 7Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer [ J ]. Breast J, 2002, 8(1):88-91.
  • 8Wong SL, Chao C. Edwards M J, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers[J]. Am Surg, 2001 , 67(6) :522 -528.
  • 9Stearns V , Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer [ J ].Ann Surg Oncol, 2002, 9(2) :235 -242.

共引文献240

同被引文献18

  • 1徐宏,王舒宝,张强,龙飞,张斌.乳腺癌哨兵淋巴结活检影响因素的多因素分析[J].肿瘤,2004,24(4):396-398. 被引量:4
  • 2申郑堂,王守满,罗沙阳.乳腺癌局部进展期新辅助化疗后哨兵淋巴结活检准确性的临床观察[J].中国医学工程,2006,14(6):583-585. 被引量:2
  • 3TSANGARIS TN, TRAD K, BRODY FJ, et al. Endoscopic axillary exploration and sentinel lymphadenectomy [J]. Surg Endosc, 1999, 13(1): 43.
  • 4MORTON DL, WEN DR, FOSHAG LJ. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanomas of the head and neck [J]. J Clin Oncol, 1993, 11(9): 1751.
  • 5TURNER RR, OLLILA DW, KRASNE DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma [J]. Ann Surg, 1997, 226(3): 271.
  • 6KHAKPOUR N, HUNT KK, KUERER HM, et al. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node [J]. Am J Surg, 2005, 190(4): 598-601.
  • 7TEAL CB, SLOCUM JP, AKIN EA, et al. Evaluation of the benefit of using blue dye in addition to radioisotope for sentinel lymph node biopsy in patients with breast cancer [J]. Breast J, 2005, 11(6): 391-393.
  • 8Louwman W J, Vuho J C, Verhoeven R H, et al. Clinical epidemiology of breast cancer in the elderly[J]. Eur J Cancer, 2007, 43 (15) :2242 -2252.
  • 9Tavafian SS, Hasani L, Aghamolaei T, et al. Prediction of breast self-examination in a sample of Iranian women : an application of the Health Belief Model[J]. BMC Womens Health, 2009, 9: 37.
  • 10Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients [ J 1. Cancer, 2004, 101 (6) : 1302 - 1310.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部